Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications
Diabetic Medicine, 06/29/2012
Herman WH et al. – Altering the cut point to define an abnormal test from ≥7 abnormal to ≥4 abnormal items improves the performance of the Michigan Neuropathy Screening Instrument (MNSI) questionnaire. The MNSI is a simple, non–invasive and valid measure of distal symmetrical peripheral neuropathy in Type 1 diabetes.
